As of June this year, based on Stryker's most recent financial report, the company's trailing twelve months EPS is $8.74. During 2025, SYK reported a per-share earnings of $8.49, which shows a rise compared to the EPS of $7.86 recorded in 2024. Stryker's EPS for the quarterly period ending on Mar 31, 2026 came in at $1.95.
The yearly earnings per share during 2025 was $8.49, a rise of 8% compared to $7.86 recorded in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at $1.95, reflecting a 14% increase compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $8.74. During 2024, the annual earnings per share was $7.86, representing a decrease of 5.8% compared to 2023.
Stryker has recorded a growth in earnings per share of 14% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 10.9% per year. Stryker had an average annual EPS growth of 14.8% in the last five years. When assessed over a ten-year period, SYK's average EPS annual growth was 8.3%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| GMED Globus Medical Inc | 18.2 | 423.7% | 28.2% | 30.8% |
| CNMD CONMED Corp | 18.38 | -64.6% | N/A | 35.7% |
| BSX Boston Scientific Corp | 18.39 | 55.6% | 63.3% | N/A |
| MDT Medtronic plc | 21.14 | 3.3% | 9.8% | 6.9% |
| JNJ Johnson & Johnson | 26.49 | 90.6% | 17.7% | 14.8% |
| SYK Stryker Corp | 34.86 | 8% | 10.9% | 14.8% |
| WAT Waters Corp | 45.41 | 0.5% | -2.9% | 5.2% |
| EW Edwards Lifesciences Corp | 45.44 | -73.6% | -9.2% | 6.9% |
| BAX Baxter International Inc | N/A | -47.2% | N/A | N/A |
| IART Integra Lifesciences Holdings Corp | N/A | -7,388.9% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.